E

EDAP TMS SA
D

EDAP

2.57000
USD
-0.13
(-4.81%)
Market Closed
Volume
3,453
EPS
-1
Div Yield
-
P/E
-4
Market Cap
95,356,712
Related Instruments
    ABT
    ABT
    1.785
    (1.34%)
    134.950 USD
    BDX
    BDX
    -0.590
    (-0.26%)
    227.450 USD
    COO
    COO
    -0.180
    (-0.20%)
    88.490 USD
    H
    HOLX
    0.180
    (0.28%)
    64.510 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    P
    PEN
    -11.41
    (-3.76%)
    291.76 USD
    RMD
    RMD
    -1.320
    (-0.57%)
    231.520 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    More
News

Title: EDAP TMS SA

Sector: Healthcare
Industry: Medical Distribution
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.